Ocular disease anatomy memberships
Loading disease count…
Disease landscape
How the disease space is organized
Anatomy-based disease distribution and directly supported inheritance evidence.
Inheritance evidence
Category counts are memberships; one disease may have multiple supported modes.
Genetics and variants
Composition of the molecular data
Gene/entity categories and consequence annotations mapped to canonical variants.
Gene and locus categories
Treemap area is proportional to the number of entities.
Variant consequence annotations
Loading consequence coverage…
Therapeutics
Clinical stage and evidence structure
Direct therapeutic evidence remains distinct from target-overlap discovery relationships.
Source-reported maximum drug development stage
Highest recorded development stage for each canonical drug entity; missing stage values are shown separately.
Disease–drug relationship space
Unique disease–drug pairs classified by direct therapeutic evidence and target overlap.
Target-overlap-only pairs are discovery connections and must not be interpreted as treatment assertions.
Clinical evidence
Trials and clinical reports
Unique clinical evidence records are shown as central entities, with their disease and drug association layers around them.
Clinical trials
Unique trial records and their many-to-many links to diseases and drugs.
Clinical reports
Unique report records and their many-to-many links to diseases and drugs.
How to read this:
“Entities” means unique records in ODDB (one trial or one clinical report).
Disease associations and drug associations are relationship rows, so their counts can be higher than the number of entities because one record may link to multiple diseases and/or drugs.
Scientific statistics
Disease, gene and variant rankings
Select Top 20, 30, 40 or a custom number, search records, reorder results and export publication-ready charts and tabular data. Stacked chromosome colors show the distribution within each canonical entity.
Loading ODDB release-based statistics…
Genomic landscape
Chromosome and ocular disease category distributions
Distinct disease-associated genes and variants. A gene or variant may contribute to more than one disease category, so totals across category memberships must not be treated as unique entities.
Clinical and therapeutic landscape
Trials, candidate therapeutics and evidence
Trial phases refer to the source clinical trial records, not each drug's maximum development stage. An association inferred from shared trial membership does not prove an indication or trial-arm assignment.
Retinitis pigmentosa case study and interactive network
Disease–gene–drug connectivity
Select an ocular disease, explore disease–gene associations, direct disease–drug evidence and curated drug targets. Target-overlap-only edges are clearly separated from direct evidence.
Disease
Gene
Drug
Solid: observed links · Dashed: target-overlap-only discovery links
PNG saves the labeled interactive radial view. SVG uses a spacious, publication-friendly layout with all selected node names. Both include only the currently selected network.
Interpretation: target overlap supports candidate discovery only; it is not evidence of clinical benefit. Numbers and node visibility depend on the selected disease and limit.
Knowledge flow maps
Follow ODDB relationships across data layers
Explore four focused Sankey views rather than one overloaded diagram. Select a flow, adjust the number of disease nodes, and tap or hover nodes for full labels.
Disease classification flow
Hover or tap for full labels and counts.
Click a disease or anatomy node to open it in Explore.
On small screens, swipe horizontally across the chart.
Relationship maps
Explore cross-layer connectivity
Swipe, use the arrows, or choose a map to move through circular relationship views. Edge width reflects the number of underlying ODDB associations.
Drag to pan · pinch/scroll to zoom · tap/hover for full labels and counts.
Labels are shortened on the circle; full terms are shown in tooltips.
Usage statistics
ODDB usage and visitors
Visitor counts, country-level usage, downloads and popular records will be added after production analytics are deployed. Only aggregated, privacy-conscious public statistics will be shown.
Production analytics
Not enabled on this local development instance.